Spero raises $51.7M in series C

By Chris Lieu | Mar 8, 2017 | 11:21 PM GMT

Anti-infective play Spero Therapeutics LLC (Cambridge, Mass.) raised $51.7 million

Read the full 101 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE